Log in
NYSE:TARO

Taro Pharmaceutical Industries SEC Filings & 10K Form

$70.89
+0.51 (+0.72 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$70.21
Now: $70.89
$71.19
50-Day Range
$57.34
MA: $62.48
$72.22
52-Week Range
$53.95
Now: $70.89
$99.69
Volume12,939 shs
Average Volume36,406 shs
Market Capitalization$2.71 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.79

SEC Filings

Taro Pharmaceutical Industries (NYSE:TARO) SEC Filings

DateFilerForm TypeView
11/04/2020
1:03 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2020
4:23 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2020
4:15 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/19/2020
5:05 AM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/06/2020
12:11 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2020
10:53 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2019
1:25 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2019
1:09 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2019
1:03 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2019
8:14 PM
Taro Pharmaceutical Industries (Subject)
Form SC TO-I/A
12/06/2019
7:46 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2019
5:02 PM
Taro Pharmaceutical Industries (Subject)
Form SC TO-I/A
11/15/2019
3:35 PM
Taro Pharmaceutical Industries (Subject)
Form SC TO-I
11/15/2019
9:09 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2019
4:09 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2019
4:02 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
8:29 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2019
3:41 PM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
05/16/2019
12:32 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2019
1:15 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2019
4:09 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2018
7:41 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2018
4:18 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2018
4:20 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2018
2:28 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2018
4:20 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2018
1:01 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2018
10:29 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2018
3:24 PM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
05/11/2018
2:30 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2018
4:23 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2018
3:21 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.